Free Trial
→ A New Way to Double Your Retirement Income? (From Investors Alley) (Ad)tc pixel
OTCMKTS:EDTXF

Spectral Diagnostics 11/9/2023 Earnings Report

Spectral Diagnostics logo
$1.17 +0.02 (+1.34%)
As of 03:06 PM Eastern
ProfileEarnings History

Spectral Diagnostics EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Spectral Diagnostics Revenue Results

Actual Revenue
$0.30 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Spectral Diagnostics Announcement Details

Quarter
Date
11/9/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Spectral Diagnostics' next earnings date is estimated for Friday, November 7, 2025, based on past reporting schedules.

Conference Call Resources

Spectral Diagnostics Earnings Headlines

Spectral Medical Receives US$3 Million From Vantive
August 25, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/25/3138361/0/en/spectral-medical-receives-us-3-million-from-vantive.html
Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock
August 12, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/12/3132084/0/en/spectral-medical-and-vantive-announce-topline-results-from-spectral-s-tigris-trial-evaluating-pmx-hemoadsorption-therapy-for-endotoxic-septic-shock.html
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel
September 5 at 2:00 AM  |  Stansberry Research (Ad)
Spectral Medical Announces Second Quarter and Provides Corporate Update
August 8, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/08/3130080/0/en/spectral-medical-announces-second-quarter-and-provides-corporate-update.html
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
July 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/04/3110481/0/en/spectral-medical-inc-announces-filing-of-base-shelf-prospectus.html
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
June 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/06/3095233/0/en/spectral-medical-inc-announces-results-of-annual-meeting-of-shareholders.html
See More Spectral Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Spectral Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spectral Diagnostics and other key companies, straight to your email.

About Spectral Diagnostics

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics (OTCMKTS:EDTXF) and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

View Spectral Diagnostics Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles